Skip to content
PeptideHormone

Octreotide vs Somatostatin

A long-acting somatostatin analog used to suppress GH and other hormones. The brake on the growth-hormone axis — and much else. Side by side: type, evidence tier, receptor, molecular weight, and half-life — the same fields as each monograph, rearranged so the engineering difference is visible.

Octreotide
Somatostatin
SST
Also known asSandostatin
TypeAnalogEndogenous
EvidenceEstablishedEstablished
FamilyGrowth & repairGrowth & repair
ClassSomatostatin analog (cyclic octapeptide)Cyclic peptide (14 and 28 aa forms)
ReceptorSomatostatin receptors (SSTR2 and SSTR5 preferential)Somatostatin receptors SSTR1–SSTR5
Molecular weight~1,019.2 Da~1,637.9 Da
Half-life
~1.5 h (subcutaneous; LAR depot ~monthly)
Model dosing
~1–3 min (very short)
Model dosing
Based onSomatostatinNative hormone

Half-life bars are on a logarithmic scale across the molecules shown. Reference values for the native or representative form — educational only, not medical or dosing advice.

Common questions

What is the difference between Octreotide and Somatostatin?
Octreotide is an engineered analog based on Somatostatin; Somatostatin is an endogenous hormone. Octreotide signals at Somatostatin receptors (SSTR2 and SSTR5 preferential); Somatostatin signals at Somatostatin receptors SSTR1–SSTR5.
How do the half-lives of Octreotide and SST compare?
The reported circulating half-life of Octreotide is ~1.5 h (subcutaneous; LAR depot ~monthly); Somatostatin is ~1–3 min (very short). These are reference values for the native or representative form — educational only, not dosing advice.
Is Octreotide the same as Sandostatin?
Sandostatin is a brand name of Octreotide. This comparison describes the molecules, not branded products.

Prefer the other order? Somatostatin vs Octreotide. Or open the interactive comparison tool to add more molecules.